Rafal Goraczniak

Dr. Rafal Goraczniak is the co-founder of Ceptur Therapeutics and its Director of Platform Development. Together with Dr. Samuel Gunderson, he is the inventor of the Company’s U1 Adaptor gene silencing technology. Dr. Gorczniak is the author of more than 30 scientific publications on the biochemistry of mRNA processing and is an inventor on several patents on U1 Adaptors and their applications. He has also over 10 years of experience in the design and manufacturing of oligonucleotide bioconjugates. Dr. Goraczniak earned his MSc in molecular biology and his Ph.D. in biochemistry at the Adam Mickiewicz University, Poznan, Poland. Subsequently, he was a special fellow at the Cleveland Clinic Foundation and completed his post-doctoral fellowships at the Pennsylvania College of Optometry and at the University of Medicine and Dentistry of New Jersey.